We aimed to review the current state-of-the-art imaging methods used for primary and secondary staging of prostate cancer, mainly focusing on multiparametric magnetic resonance imaging and positron-emission tomography/computed tomography with new radiotracers. An expert panel of urologists, radiologists and nuclear medicine physicians with wide experience in prostate cancer led a PubMed/MEDLINE search for prospective, retrospective original research, systematic review, meta-analyses and clinical guidelines for local and systemic staging of the primary tumor and recurrence disease after treatment. Despite magnetic resonance imaging having low sensitivity for microscopic extracapsular extension, it is now a mainstay of prostate cancer diagnosis and local staging, and is becoming a crucial tool in treatment planning. Cross-sectional imaging for nodal staging, such as computed tomography and magnetic resonance imaging, is clinically useless even in high-risk patients, but is still suggested by current clinical guidelines. Positron-emission tomography/computed tomography with newer tracers has some advantage over conventional images, but is not cost-effective. Bone scan and computed tomography are often useless in early biochemical relapse, when salvage treatments are potentially curative. New imaging modalities, such as prostate-specific membrane antigen positron-emission tomography/computed tomography and whole-body magnetic resonance imaging, are showing promising results for early local and systemic detection. Newer imaging techniques, such as multiparametric magnetic resonance imaging, whole-body magnetic resonance imaging and positron-emission tomography/computed tomography with prostate-specific membrane antigen, have the potential to fill the historical limitations of conventional imaging methods in some clinical situations of primary and secondary staging of prostate cancer.

State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer / Schiavina, R.; Chessa, F.; Borghesi, M.; Gaudiano, C.; Bianchi, L.; Corcioni, B.; Castellucci, P.; Ceci, F.; Ceravolo, I.; Barchetti, G.; Del Monte, M.; Campa, R.; Catalano, C.; Panebianco, V.; Nanni, C.; Fanti, S.; Minervini, A.; Porreca, A.; Brunocilla, E.. - In: INTERNATIONAL JOURNAL OF UROLOGY. - ISSN 0919-8172. - 26:1(2019), pp. 18-30. [10.1111/iju.13797]

State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer

Ceravolo I.;Barchetti G.;Del Monte M.;Campa R.;Catalano C.;Panebianco V.;
2019

Abstract

We aimed to review the current state-of-the-art imaging methods used for primary and secondary staging of prostate cancer, mainly focusing on multiparametric magnetic resonance imaging and positron-emission tomography/computed tomography with new radiotracers. An expert panel of urologists, radiologists and nuclear medicine physicians with wide experience in prostate cancer led a PubMed/MEDLINE search for prospective, retrospective original research, systematic review, meta-analyses and clinical guidelines for local and systemic staging of the primary tumor and recurrence disease after treatment. Despite magnetic resonance imaging having low sensitivity for microscopic extracapsular extension, it is now a mainstay of prostate cancer diagnosis and local staging, and is becoming a crucial tool in treatment planning. Cross-sectional imaging for nodal staging, such as computed tomography and magnetic resonance imaging, is clinically useless even in high-risk patients, but is still suggested by current clinical guidelines. Positron-emission tomography/computed tomography with newer tracers has some advantage over conventional images, but is not cost-effective. Bone scan and computed tomography are often useless in early biochemical relapse, when salvage treatments are potentially curative. New imaging modalities, such as prostate-specific membrane antigen positron-emission tomography/computed tomography and whole-body magnetic resonance imaging, are showing promising results for early local and systemic detection. Newer imaging techniques, such as multiparametric magnetic resonance imaging, whole-body magnetic resonance imaging and positron-emission tomography/computed tomography with prostate-specific membrane antigen, have the potential to fill the historical limitations of conventional imaging methods in some clinical situations of primary and secondary staging of prostate cancer.
imaging; prostate cancer; review; humans; male; multimodal imaging; neoplasm recurrence, local; neoplasm staging; practice guidelines as topic; preoperative period; prostate-specific antigen; prostatic neoplasms; whole body imaging
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer / Schiavina, R.; Chessa, F.; Borghesi, M.; Gaudiano, C.; Bianchi, L.; Corcioni, B.; Castellucci, P.; Ceci, F.; Ceravolo, I.; Barchetti, G.; Del Monte, M.; Campa, R.; Catalano, C.; Panebianco, V.; Nanni, C.; Fanti, S.; Minervini, A.; Porreca, A.; Brunocilla, E.. - In: INTERNATIONAL JOURNAL OF UROLOGY. - ISSN 0919-8172. - 26:1(2019), pp. 18-30. [10.1111/iju.13797]
File allegati a questo prodotto
File Dimensione Formato  
Schiavina_State-of-the-art_2018.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 647.18 kB
Formato Adobe PDF
647.18 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1291912
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 14
social impact